title: Importance of insulin resistance to vascular repair and regeneration.
abstract: Metabolic insulin resistance is apparent across a spectrum of clinical disorders, including obesity and diabetes, and is characterized by an adverse clustering of cardiovascular risk factors related to abnormal cellular responses to insulin. These disorders are becoming increasingly prevalent and represent a major global public health concern because of their association with significant increases in atherosclerosis-related mortality. Endogenous repair mechanisms are thought to retard the development of vascular disease, and a growing evidence base supports the adverse impact of the insulin-resistant phenotype upon indices of vascular repair. Beyond the impact of systemic metabolic changes, emerging data from murine studies also provide support for abnormal insulin signaling at the level of vascular cells in retarding vascular repair. Interrelated pathophysiological factors, including reduced nitric oxide bioavailability, oxidative stress, altered growth factor activity, and abnormal intracellular signaling, are likely to act in conjunction to impede vascular repair while also driving vascular damage. Understanding of these processes is shaping novel therapeutic paradigms that aim to promote vascular repair and regeneration, either by recruiting endogenous mechanisms or by the administration of cell-based therapies.
authors: Multidisciplinary Cardiovascular Research Centre, LIGHT Laboratories, The University of Leeds, Leeds LS2 9JT, UK. r.cubbon@leeds.ac.uk
authors: Richard M
authors: RM
authors: Cubbon
authors: Ben N
authors: BN
authors: Mercer
authors: Anshuman
authors: A
authors: Sengupta
authors: Mark T
authors: MT
authors: Kearney
mesh_terms: D000818:Animals; D048909:Diabetes Complications / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000378:metabolism / Q000503:physiopathology; D051379:Mice; D009569:Nitric Oxide / Q000378:metabolism; D009765:Obesity / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D012038:Regeneration; D014652:Vascular Diseases / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy
chemical_list: D007328:Insulin; D009569:Nitric Oxide